Lee P - Search Results

1

Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity.

Moreira D, Sampath S, Won H, White SV, Su YL, Alcantara M, Wang C, Lee P, Maghami E, Massarelli E, Kortylewski M. Moreira D, et al. Among authors: lee p. J Clin Invest. 2021 Jan 19;131(2):e137001. doi: 10.1172/JCI137001. J Clin Invest. 2021. PMID: 33232304 Free PMC article.

2

Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring a POLE Mutation.

Gong J, Wang C, Lee PP, Chu P, Fakih M. Gong J, et al. Among authors: lee pp. J Natl Compr Canc Netw. 2017 Feb;15(2):142-147. doi: 10.6004/jnccn.2017.0016. J Natl Compr Canc Netw. 2017. PMID: 28188185

3

Immune profiling of microsatellite instability-high and polymerase ε (POLE)-mutated metastatic colorectal tumors identifies predictors of response to anti-PD-1 therapy.

Wang C, Gong J, Tu TY, Lee PP, Fakih M. Wang C, et al. Among authors: lee pp. J Gastrointest Oncol. 2018 Jun;9(3):404-415. doi: 10.21037/jgo.2018.01.09. J Gastrointest Oncol. 2018. PMID: 29998005 Free PMC article.

4

Connecting blood and intratumoral T_reg cell activity in predicting future relapse in breast cancer.

Wang L, Simons DL, Lu X, Tu TY, Solomon S, Wang R, Rosario A, Avalos C, Schmolze D, Yim J, Waisman J, Lee PP. Wang L, et al. Among authors: lee pp. Nat Immunol. 2019 Sep;20(9):1220-1230. doi: 10.1038/s41590-019-0429-7. Epub 2019 Jul 8. Nat Immunol. 2019. PMID: 31285626 Free PMC article.

5

Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome.

Fakih M, Ouyang C, Wang C, Tu TY, Gozo MC, Cho M, Sy M, Longmate JA, Lee PP. Fakih M, et al. Among authors: lee pp. J Clin Invest. 2019 Oct 1;129(10):4464-4476. doi: 10.1172/JCI127046. J Clin Invest. 2019. PMID: 31524634 Free PMC article.

6

Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS.

Kalvala A, Wallet P, Yang L, Wang C, Li H, Nam A, Nathan A, Mambetsariev I, Poroyko V, Gao H, Chu P, Sattler M, Bild A, Manuel ER, Lee PP, Jolly MK, Kulkarni P, Salgia R. Kalvala A, et al. Among authors: lee pp. J Clin Med. 2019 Oct 18;8(10):1726. doi: 10.3390/jcm8101726. J Clin Med. 2019. PMID: 31635338 Free PMC article.

7

STAT3 Activation-Induced Fatty Acid Oxidation in CD8⁺ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth.

Zhang C, Yue C, Herrmann A, Song J, Egelston C, Wang T, Zhang Z, Li W, Lee H, Aftabizadeh M, Li YJ, Lee PP, Forman S, Somlo G, Chu P, Kruper L, Mortimer J, Hoon DSB, Huang W, Priceman S, Yu H. Zhang C, et al. Among authors: lee h, lee pp. Cell Metab. 2020 Jan 7;31(1):148-161.e5. doi: 10.1016/j.cmet.2019.10.013. Epub 2019 Nov 21. Cell Metab. 2020. PMID: 31761565 Free PMC article.

8

A Pilot Feasibility Study of Yttrium-90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases.

Wang C, Park J, Ouyang C, Longmate JA, Tajon M, Chao J, Lim D, Sandhu J, Yin HH, Pillai R, Gozo MC, Avalos C, Egelston CA, Lee PP, Fakih M. Wang C, et al. Among authors: lee pp. Oncologist. 2020 May;25(5):382-e776. doi: 10.1634/theoncologist.2019-0924. Epub 2019 Dec 19. Oncologist. 2020. PMID: 31857446 Free PMC article.

9

Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors.

Zhao D, Mambetsariev I, Li H, Chen C, Fricke J, Fann P, Kulkarni P, Xing Y, Lee PP, Bild A, Massarelli E, Koczywas M, Reckamp K, Salgia R. Zhao D, et al. Among authors: lee pp. Lung Cancer. 2020 Aug;146:174-181. doi: 10.1016/j.lungcan.2020.05.025. Epub 2020 May 24. Lung Cancer. 2020. PMID: 32554069 Free PMC article.

10

Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer.

Egelston C, Guo W, Yost S, Lee JS, Rose D, Avalos C, Ye J, Frankel P, Schmolze D, Waisman J, Lee P, Yuan Y. Egelston C, et al. Among authors: lee js, lee p. J Immunother Cancer. 2021 Mar;9(3):e002084. doi: 10.1136/jitc-2020-002084. J Immunother Cancer. 2021. PMID: 33757987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,005 results

Search Page